- Home
- MNPR vs ALOT Comparison
MNPR vs ALOT Comparison
Compare MNPR & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- ALOT
- Stock Information
- Founded
- MNPR 2014
- ALOT 1969
- Country
- MNPR United States
- ALOT United States
- Employees
- MNPR N/A
- ALOT N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- ALOT Computer peripheral equipment
- Sector
- MNPR Health Care
- ALOT Technology
- Exchange
- MNPR Nasdaq
- ALOT Nasdaq
- Market Cap
- MNPR 95.5M
- ALOT 105.3M
- IPO Year
- MNPR 2019
- ALOT N/A
- Fundamental
- Price
- MNPR $18.09
- ALOT $14.10
- Analyst Decision
- MNPR Strong Buy
- ALOT
- Analyst Count
- MNPR 3
- ALOT 0
- Target Price
- MNPR $27.33
- ALOT N/A
- AVG Volume (30 Days)
- MNPR 1.5M
- ALOT 9.2K
- Earning Date
- MNPR 11-08-2024
- ALOT 12-04-2024
- Dividend Yield
- MNPR N/A
- ALOT N/A
- EPS Growth
- MNPR N/A
- ALOT 591.76
- EPS
- MNPR N/A
- ALOT 0.83
- Revenue
- MNPR N/A
- ALOT $150,643,000.00
- Revenue This Year
- MNPR N/A
- ALOT N/A
- Revenue Next Year
- MNPR N/A
- ALOT N/A
- P/E Ratio
- MNPR N/A
- ALOT $17.02
- Revenue Growth
- MNPR N/A
- ALOT 0.29
- 52 Week Low
- MNPR $1.37
- ALOT $11.83
- 52 Week High
- MNPR $38.50
- ALOT $18.83
- Technical
- Relative Strength Index (RSI)
- MNPR 60.19
- ALOT 54.67
- Support Level
- MNPR $16.26
- ALOT $13.83
- Resistance Level
- MNPR $19.70
- ALOT $14.25
- Average True Range (ATR)
- MNPR 2.15
- ALOT 0.53
- MACD
- MNPR -0.07
- ALOT 0.12
- Stochastic Oscillator
- MNPR 74.36
- ALOT 88.33
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.